Fujii H, Nakajima M, Aoyagi T, Tsuruo T
Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan.
Biol Pharm Bull. 1996 Jan;19(1):6-10. doi: 10.1248/bpb.19.6.
We investigated the effects of several types of aminopeptidase inhibitors on tumor cell-associated aminopeptidase activity and invasion. The aminopeptidase expressed by the human metastatic HT1080 fibrosarcoma cells was effectively suppressed by actinonin A, bestatin, leuhistin and matlystatin A, which are capable of inhibiting the purified aminopeptidase N, but not by arphamenine B specific for aminopeptidase B. The aminopeptidase N inhibitors inhibited HT1080 cells from degrading the subendothelial matrix and from invading into Matrigel in parallel with their aminopeptidase inhibitory activities. Matlystatin A, with multiple inhibitory activity against both aminopeptidase N and matrix metalloproteinases (MMP), was the most effective inhibitor of invasion. However, leuhistin and bestatin, without MMP inhibitory activity, also exhibited significant inhibition of invasion. The results suggest that aminopeptidase N plays a crucial role in the degradation and invasion of extracellular matrices by fibrosarcoma cells and that aminopeptidase inhibitors may be useful for preventing the spread of malignant tumors.
我们研究了几种类型的氨肽酶抑制剂对肿瘤细胞相关氨肽酶活性及侵袭的影响。人转移性HT1080纤维肉瘤细胞表达的氨肽酶可被Actinonin A、抑氨肽酶素、亮抑蛋白酶肽和马立司他A有效抑制,这些抑制剂能够抑制纯化的氨肽酶N,但对氨肽酶B特异的阿弗他明B则无抑制作用。氨肽酶N抑制剂抑制HT1080细胞降解内皮下基质及侵袭基质胶的能力与其氨肽酶抑制活性呈平行关系。对氨肽酶N和基质金属蛋白酶(MMP)均具有多重抑制活性的马立司他A是最有效的侵袭抑制剂。然而,不具有MMP抑制活性的亮抑蛋白酶肽和抑氨肽酶素也表现出显著的侵袭抑制作用。结果表明,氨肽酶N在纤维肉瘤细胞对细胞外基质的降解及侵袭过程中起关键作用,且氨肽酶抑制剂可能对预防恶性肿瘤的扩散有用。